查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927702

全球阿兹海默症诊断市场按类型、诊断技术、最终用户、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032年）

Alzheimer's Disease Diagnostics Market, Report By Type, By Diagnostic Technique, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 382 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年阿兹海默症诊断市场规模价值为 921.901 亿美元，从 2025 年到 2032 年的复合年增长率为 11.19%。

由于神经退化性疾病盛行率不断上升、人口老化以及人们对早期诊断意识的增强，全球阿兹海默症诊断市场正稳步增长。基于生物标记的检测、神经影像学和血液诊断等技术的进步提高了检测准确率，从而能够更早地进行干预。政府的支持性政策、不断增加的研究经费以及诊断服务的普及，进一步推动了已开发经济体和新兴经济体的市场成长。

阿兹海默症诊断市场—市场动态

阿兹海默症率上升与人口老化

全球人口老化和阿兹海默症发病率上升是推动先进诊断解决方案需求的主要因素。早期准确诊断对于有效疾病管理、制定合适的治疗方案以及提高患者生活品质至关重要。例如，根据欧洲脑理事会2025年1月发布的报告，目前欧洲约有700万人患有阿兹海默症，预计到2030年，由于人口老化，这一数字将增加至约1,400万。这凸显了该疾病日益加重的公共卫生负担。诊断技术的进步，包括基于生物标记的检测和非侵入性神经影像技术，以及医疗专业人员意识提升的提高，正在加速诊断方法的应用。同时，诊断设备製造商持续加大研发投入，正在强化产品平臺，并推动全球诊断能力的提升。

阿兹海默症诊断市场—市场細項分析：

全球阿兹海默症诊断市场按类型、诊断技术、最终用户和地区进行细分。

按类型划分，阿兹海默症可分为早发性阿兹海默症和晚发性阿兹海默症。由于晚发性阿兹海默症在老年人中发病率较高，因此占据了市场的大部分份额。此外，全球老年人口的增长和预期寿命的延长也显着促进了晚发性阿兹海默症病例的增加。老年人诊断意识的提高和医疗保健利用率的上升进一步巩固了该细分市场的主导地位。

依诊断技术划分，市场可分为神经影像学、生物标记检测、基因检测、认知功能检测和其他诊断方法。神经影像学和基于生物标记的诊断方法因其诊断准确率高且在临床应用中日益普及，占据了较大的市场份额。影像技术的进步和生物标记的发现使得阿兹海默症的早期可靠检测成为可能。此外，精准医疗投入的增加以及这些技术在临床试验中的应用，也推动了其广泛普及。

依最终用户划分，市场可分为医院/诊所、诊断检查室、研究机构和其他机构。医院和诊断检查室凭藉其庞大的患者数量和先进的诊断基础设施，占据市场主导地位。这些机构也受益于熟练的医疗专业人员和综合诊断服务，从而能够及时准确地检测出疾病。此外，医院筛检计画的增加和病患转诊量的上升进一步巩固了其市场主导地位。

阿兹海默症诊断市场—区域洞察

北美在阿兹海默症诊断市场占据主导地位，这主要归功于其先进的医疗基础设施、较高的公众认知度以及创新诊断技术的快速普及。这些因素有助于早期发现和及时干预，在有效管理阿兹海默症方面发挥着至关重要的作用。欧洲紧随其后，这得益于其完善的研究设施和鼓励投资新型诊断方法和技术的政府医疗政策。在亚太地区，人口老化显着加剧，加上医疗服务可近性的提高以及对诊断基础设施投资的增加（尤其是在中国和印度等主要市场），预计将推动市场快速成长。这些国家正优先加强其医疗体系，以应对日益增长的阿兹海默症率。同时，由于大众对阿兹海默症的认知度提高以及诊断能力的进步，拉丁美洲和中东及非洲预计将实现温和增长。这有望最终改善这些地区的患者管理和治疗效果。

阿兹海默症诊断市场—国家/地区洞察

美国在阿兹海默症诊断市场保持主导地位。这得益于美国诊断测试的高利用率、健全的健保体系（使患者能够获得最尖端科技）以及众多推动创新的主要企业。这些因素为新诊断方法的快速发展和广泛应用创造了有利环境。在欧洲，德国、英国和法国发挥关键作用。这些国家受益于先进的医疗保健体系，该体系促进了高品质的医疗保健，并持续进行研发活动，旨在提高诊断准确性并开发新的检测方案。同时，中国和印度已成为高成长市场，这得益于其庞大的患者群体和不断扩展的诊断网络，从而提高了基本服务的可及性。此外，两国越来越重视疾病的早期检测，这与全球预防性医疗保健的趋势相符。这些因素共同作用，使这两个国家在诊断领域拥有加速成长的优势，并有助于改善阿兹海默症患者的治疗效果。

目录

第一章阿兹海默症诊断市场概览

  • 调查范围
  • 市场预测期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章阿兹海默症诊断的关键市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章阿兹海默症诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景分析
  • 法规结构分析

第五章阿兹海默症诊断市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章阿兹海默症诊断市场概况

  • 2024年阿兹海默症诊断市占率分析
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章阿兹海默症诊断市场（按类型划分）

  • 概述
    • 细分市场占有率分析：按类型
    • 早发性阿兹海默症
    • 晚发性阿兹海默症
    • 其他的

第八章阿兹海默症诊断市场（按诊断技术划分）

  • 概述
    • 依诊断技术进行细分市场份额分析
    • 神经影像学
    • 生物标记检测
    • 基因检测
    • 认知功能测试
    • 其他的

第九章阿兹海默症诊断市场（按最终用户划分）

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院和诊所
    • 诊断检查室
    • 研究所
    • 其他的

第十章阿兹海默症诊断市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十一章 主要供应商分析—阿兹海默症诊断产业

  • 竞争对手仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Abbott Laboratories
    • Roche Diagnostics
    • Siemens Healthineers
    • GE HealthCare
    • Fujirebio
    • Biogen
    • Quanterix
    • C2N Diagnostics
    • Thermo Fisher Scientific
    • Danaher Corporation
    • Others

第十二章：分析师视角

简介目录
Product Code: ANV5952

The Alzheimer's disease Diagnostics Market size was valued at US$ 9,2190.10 Million in 2024, expanding at a CAGR of 11.19% from 2025 to 2032.

The global Alzheimer's disease diagnostics market is witnessing steady growth due to the rising prevalence of neurodegenerative disorders, the increasing ageing population, and growing awareness regarding early diagnosis. Technological advancements in biomarker-based testing, neuroimaging, and blood-based diagnostics are improving detection accuracy and enabling earlier intervention. Supportive government initiatives, increased research funding, and expanding access to diagnostic services are further contributing to market growth across both developed and emerging economies.

Alzheimer's Disease Diagnostics Market- Market Dynamics

Rising prevalence of Alzheimer's disease and an ageing population

The increasing global geriatric population and the rising incidence of Alzheimer's disease are key drivers fueling demand for advanced diagnostic solutions. Early and accurate diagnosis is essential for effective disease management, timely treatment planning, and improving patient quality of life. For instance, in January 2025, the European Brain Council reported that nearly 7 million people across Europe are currently living with Alzheimer's disease, and with an ageing population, this number is projected to rise to approximately 14 million by 2030, highlighting the growing public health burden of the disease. Advancements in diagnostic technologies, including biomarker-based assays and non-invasive neuroimaging techniques, combined with increasing awareness among healthcare professionals, are accelerating diagnostic adoption. In parallel, continuous R&D investments by diagnostic companies are strengthening product pipelines and expanding global diagnostic capabilities.

Alzheimer's disease Diagnostics Market- Segmentation Analysis:

The Global Alzheimer's Disease Diagnostics Market is segmented on the basis of Type, Diagnostic Technique, End User, and Region.

Based on Type, the market is categorised into Early-Onset Alzheimer's Disease and Late-Onset Alzheimer's Disease. Late-onset Alzheimer's disease holds a dominant share due to its higher prevalence among the elderly population. Additionally, the rising global geriatric population and increased life expectancy significantly contribute to the growing number of late-onset cases. Improved diagnostic awareness and higher healthcare utilisation among older adults further reinforce the dominance of this segment in the market.

Based on the diagnostic technique, the market is categorised into Neuroimaging, Biomarker Tests, Genetic Testing, Cognitive Tests, and Others. Neuroimaging and biomarker-based diagnostics account for a significant share owing to their high diagnostic accuracy and growing clinical adoption. Advancements in imaging technologies and biomarker discovery have enabled earlier and more reliable detection of Alzheimer's disease. Furthermore, increasing investments in precision medicine and the integration of these techniques into clinical trials are driving their widespread use..

Based on End User, the market is categorised into Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Others. Hospitals and diagnostic laboratories dominate due to high patient inflow and access to advanced diagnostic infrastructure. These settings also benefit from the availability of skilled healthcare professionals and integrated diagnostic services, enabling timely and accurate disease detection. Additionally, rising hospital-based screening programs and referrals further strengthen their market dominance.

Alzheimer's Disease Diagnostics Market- Geographical Insights

North America holds the leading position in the Alzheimer's disease diagnostics market, attributed to its advanced healthcare infrastructure, high levels of public awareness, and rapid adoption of innovative diagnostic technologies. These factors facilitate early detection and timely intervention, which are crucial in managing Alzheimer's disease effectively. Europe follows closely, bolstered by well-established research facilities and supportive government healthcare policies that encourage investment in new diagnostic methodologies and technologies. In the Asia-Pacific region, anticipated rapid growth is driven by a significantly ageing population, coupled with improving healthcare access and increasing investments in diagnostic infrastructure, particularly in major markets like China and India. These nations are prioritising the enhancement of their healthcare systems to address the rising prevalence of Alzheimer's. Meanwhile, Latin America and the Middle East & Africa are experiencing gradual growth as public awareness around Alzheimer's improves, alongside advancements in diagnostic capabilities, ultimately contributing to better patient management and outcomes in these regions.

Alzheimer's Disease Diagnostics Market- Country Insights

The United States maintains a dominant position in the Alzheimer's disease diagnostics market, attributable to its high utilisation of diagnostic tests, robust reimbursement frameworks that facilitate patient access to cutting-edge technologies, and the presence of leading diagnostic companies driving innovation. These factors create a conducive environment for the rapid development and adoption of new diagnostic methods. In Europe, Germany, the UK, and France play significant roles, benefiting from their advanced healthcare systems that promote high-quality care and ongoing research activities aimed at enhancing diagnostic accuracy and developing novel testing solutions. Meanwhile, China and India are emerging as high-growth markets, fueled by their large patient populations and expanding diagnostic networks that enhance accessibility to essential services. Additionally, both countries are increasingly focusing on early disease detection, aligning with global trends that emphasize proactive healthcare measures. This combination of factors positions them favorably for accelerated growth in the diagnostic landscape, contributing to improving outcomes for patients with Alzheimer's disease.

Alzheimer's disease Diagnostics Market- Competitive Landscape:

The Alzheimer's disease diagnostics market is moderately competitive, with key players prioritizing technological innovation, biomarker development, and strategic collaborations to strengthen their market presence. For instance, August 2025: BGI Genomics developed an in-house blood-based diagnostic test for Alzheimer's disease and other cognitive disorders, following China's national regulatory approval received in April 2024. The test analyses five key blood-based biomarkers, including specific tau and amyloid protein variants, as well as additional neuro-related indicators, providing clinicians with a more comprehensive understanding of underlying brain pathology. Furthermore, ongoing clinical trials for investigational diagnostic tools and novel biomarkers continue to support innovation and are significantly accelerating overall market growth. Companies are increasingly investing in advanced blood-based tests, imaging solutions, and AI-enabled diagnostic tools aimed at improving early detection and clinical outcomes. Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers are prominent leaders in this space, leveraging their extensive research capabilities to develop cutting-edge diagnostic technologies. GE HealthCare and Fujirebio specialise in advanced imaging techniques and biomarker assays, further advancing diagnostic accuracy. Additionally, Biogen and Quanterix focus on innovative therapies and diagnostic solutions to address the complexities of Alzheimer's. C2N Diagnostics, Thermo Fisher Scientific, and Danaher Corporation also contribute significantly, providing specialized tools and technologies for early detection. Together, these companies shape a dynamic landscape that is critical for enhancing understanding and management of Alzheimer's disease through improved diagnostic capabilities.

Recent Developments:

On May 16, 2025, the FDA cleared the first in vitro blood test to aid in the diagnosis of Alzheimer's disease. Developed by Fujirebio Diagnostics, Inc., the Lumipulse G pTau217 / B-Amyloid 1-42 Plasma Ratio is designed to detect amyloid plaques in adults aged 55 and older who exhibit symptoms of cognitive impairment.

In August 2025, C2N Diagnostics, LLC announced a major global expansion of its PrecivityAD2 blood test, reaching additional healthcare providers across Asia, Europe, Latin America, and the Middle East. This initiative aims to broaden access to high-precision Alzheimer's disease diagnostics, particularly in regions with limited imaging infrastructure.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • GE HealthCare
  • Fujirebio
  • Biogen
  • Quanterix
  • C2N Diagnostics
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Early-Onset Alzheimer's Disease
  • Late-Onset Alzheimer's Disease
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY DIAGNOSTIC TECHNIQUE ANALYSIS, 2019 - 2032

  • Neuroimaging
  • Biomarker Tests
  • Genetic Testing
  • Cognitive Tests
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Others

GLOBAL ALZHEIMER'S DISEASE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Alzheimer's Disease Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Alzheimer's Disease Diagnostics Market Snippet by Type
    • 2.1.2. Alzheimer's Disease Diagnostics Market Snippet by Diagnostic Technique
    • 2.1.3. Alzheimer's Disease Diagnostics Market Snippet by End User
    • 2.1.4. Alzheimer's Disease Diagnostics Market Snippet by Country
    • 2.1.5. Alzheimer's Disease Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Alzheimer's Disease Diagnostics Key Market Trends

  • 3.1. Alzheimer's Disease Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Alzheimer's Disease Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Alzheimer's Disease Diagnostics Market Opportunities
  • 3.4. Alzheimer's Disease Diagnostics Market Future Trends

4. Alzheimer's Disease Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Alzheimer's Disease Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Alzheimer's Disease Diagnostics Market Landscape

  • 6.1. Alzheimer's Disease Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Alzheimer's Disease Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Early-Onset Alzheimer's Disease
    • 7.1.3. Late-Onset Alzheimer's Disease
    • 7.1.4. Others

8. Alzheimer's Disease Diagnostics Market - By Diagnostic Technique

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnostic Technique, 2024&2032 (%)
    • 8.1.2. Neuroimaging
    • 8.1.3. Biomarker Tests
    • 8.1.4. Genetic Testing
    • 8.1.5. Cognitive Tests
    • 8.1.6. Others

9. Alzheimer's Disease Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Research Institutes
    • 9.1.5. Others

10. Alzheimer's Disease Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Alzheimer's Disease Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Alzheimer's Disease Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Alzheimer's Disease Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Alzheimer's Disease Diagnostics Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Alzheimer's Disease DiagnosticsKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostic Technique, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Alzheimer's Disease Diagnostics Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Siemens Healthineers
    • 11.2.4. GE HealthCare
    • 11.2.5. Fujirebio
    • 11.2.6. Biogen
    • 11.2.7. Quanterix
    • 11.2.8. C2N Diagnostics
    • 11.2.9. Thermo Fisher Scientific
    • 11.2.10. Danaher Corporation
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us